Zenition 30 offers versatility for a range of clinical procedures which include orthopedics, trauma, spine, pain management and other surgical procedures. Featuring Philips’ latest-generation flat detector technology, advanced imaging algorithms, and personalized user profiles, the new system delivers superior image quality, dose efficiency, and workflow customization. From the moment a surgeon logs on, the Zenition 30 automatically adjusts to their preferred settings and way of working, contributing to fewer manual adjustments and more first-time-right imaging. In addition to rapid set-up and protocol selection, the Zenition 30 also offers surgeons much greater control over C-arm positioning during surgical procedures.
In independent usability studies involving clinicians around the world who were offered hands-on experience of the Zenition 30 in simulated environments, 95% said they believed its enhanced surgeon control would allow them to work independently , while 84% believed that Zenition 30’s personalized image quality profiles meant fewer images might be needed during a procedure because the first image already incorporates their preferred settings .
As part of its commitment to doing business sustainably and helping its customers make responsible choices, Philips has designed the Zenition 30 to have a 25% increased product lifetime  and also has a refurbished program available, making it ‘circular-ready’ for repair, refurbishment, and recycling .
Other C-arm systems in Philips’ Zenition series are the Zenition 50, Zenition 70, and the recently launched Zenition 10 .
 Zenition 30 mobile C-arm systems are available for sale in a limited number of countries. Please check with a local representative for availability in your market. Pending 510 (k) not available for sale in the USA.
 Zenition 10 mobile C-arm system is not available in the USA.
 Results were obtained during a claims substantiation study performed in February and September 2022 by Use-Lab GmbH, an independent company. Response is based on 37 clinicians around the world, who answered a questionnaire subsequent to a usability study with additional hands-on time with the system.
 Results were obtained during a claims substantiation study performed in February and September 2022 by Use-Lab GmbH, an independent company. Response is based on 50 clinicians around the world, who answered a questionnaire subsequent to a usability study with additional hands-on time with the system.
 Compared to its predecessor, BV Endura 2.3.